Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2009

Study Completion Date

August 31, 2009

Conditions
Rectal Cancer
Interventions
RADIATION

Preoperative chemoradiotherapy

Preoperative chemoradiation with conventional radiotherapy (46 Gy in 23 fractions to the whole pelvis followed by a boost dose of 4 Gy in 2 fractions) and oral fluoropyrimidine (capecitabine 825 mg/m2 twice per day without weekend breaks during whole radiotherapy period)

RADIATION

Postoperative chemoradiotherapy

Postoperative radiotherapy with conventional radiation schedule (50 Gy in 25 fractions to the whole pelvis) and oral fluoropyrimidine (capecitabine 825 mg/m2 twice per day without weekend breaks during whole radiotherapy period)

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER